Eldoin Syrup (Erdocthein)

Adult dose

Children and adults weighing over 30 kg: Take 350 mg (about 10mL of the prepared solution) orally twice a day.

Child dose

Body weight 15～19 kg: Administer 175 mg (approximately 5 mL of the reconstituted solution) orally twice daily. Body weight 20～30 kg: Administer 175 mg (approximately 5 mL of the reconstituted solution) orally three times daily. Children weighing 30 kg or more and adults: Administer 350 mg (approximately 10 mL of the reconstituted solution) orally twice daily.

This medication must not be used in certain patients. For example, patients who are allergic to this drug or its components should not take it. Additionally, it should not be used in patients with liver cirrhosis or specific enzyme deficiencies, as it may interfere with the metabolism of a substance called methionine in the body. Patients with peptic ulcers and severe kidney dysfunction should also refrain from taking this medication. Its use is prohibited in patients with severe liver impairment. Caution should be exercised when administering to patients with slightly impaired liver function. For such patients, the daily dosage should not exceed 300mg. Diabetic patients or those on a calorie-restricted diet should also be careful when taking this medication. Overdosing may lead to symptoms such as sweating, dizziness, and facial flushing. Neurological and respiratory symptoms such as headache, cold symptoms, and difficulty breathing have also been reported. Moreover, gastrointestinal symptoms such as dysgeusia, nausea, vomiting, diarrhea, abdominal pain, and heartburn, as well as skin symptoms like hives, rashes, and eczema may also occur. Various adverse reactions associated with this medication, including fatigue, dyspepsia, palpitations, swelling of the face or body, and itching have been reported. Taking this medication along with cough syrups may increase the risk of inadequate mucus clearance from the bronchi, elevating the risk of bronchial infections and spasms, so caution is advised. Women who are pregnant or may become pregnant, as well as nursing mothers, should avoid taking this medication. While no significant toxicity has been found in animal studies, its safety in humans is not assured. This medication should be kept out of reach of children, and transferring it to another container should be avoided to prevent accidents or deterioration of the drug’s quality.

• sweating
• dizziness
• flushing
• headache
• cold
• difficulty breathing
• taste disturbance
• nausea
• vomiting
• diarrhea

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is best maintained at room temperature between 1 to 30 degrees Celsius.

Appearance

This medication is a white crystalline powder with a strawberry flavor and taste, packaged in a high-density polyethylene (HDPE) bottle as a syrup that is used by suspending in water. When suspended in water, it appears as a white to light yellow suspension.

Package unit

25g (50mL when solvent is added)/bottle